3 companies
D'Ieteren Group
Market Cap: €9.0b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€171.40
7D
2.3%
1Y
-5.3%
argenx
Market Cap: €44.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€715.60
7D
2.1%
1Y
41.3%
UCB
Market Cap: €46.5b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€251.70
7D
4.0%
1Y
57.4%